TRACON Pharmaceuticals Inc (TCON)

Finanzdaten der TRACON Pharmaceuticals Inc-Aktie (TCON)

Gewinn- und Verlustrechnung

Vierteljährlich

*Alle Zahlen in Millionen

Enddatum des Zeitraums	2024-03-31	2023-12-31	2023-09-30	2023-06-30	2023-03-31
Periodenlänge	3 Monate	3 Monate	3 Monate	3 Monate	3 Monate
Revenues	96.72% 0.10	3.045	-	9.00	-
Operating Expenses	25.55% 3.312	2.638	1.588	9.779	7.313
Benefits Costs and Expenses	25.40% 3.268	2.606	-10.76	-	23.79
Costs And Expenses	25.40% 3.268	2.606	-10.76	9.779	14.01
Operating Income/Loss	889.19% -3.212	0.407	-1.588	-0.779	-7.313
Nonoperating Income/Loss	37.50% 0.044	0.032	12.35	-5.507	-1.191
Income/Loss From Continuing Operations Before Tax	821.64% -3.168	0.439	10.76	-6.286	-8.504
Income/Loss From Continuing Operations After Tax	821.64% -3.168	0.439	10.76	-6.286	-8.504
Net Income/Loss	821.64% -3.168	0.439	10.76	-6.286	-8.504
Preferred Stock Dividends And Other Adjustments	-	-	-	-	-
Attributable To Noncontrolling Interest	-	-	-	-	-
Basic Average Shares	4.65% 2.3895	2.2833	36.77	30.77	23.70
Diluted Average Shares	4.65% 2.3895	2.2833	36.86	30.77	23.70
Basic Earnings Per Share	6,750% -1.33	0.02	0.29	-0.20	-0.36
Diluted Earnings Per Share	6,750% -1.33	0.02	0.29	-0.20	-0.36
Participating Securities, Distributed And Undistributed Earnings/Loss, Basic	-	-	-	-	-